浩宇生醫 6872 Cash Flow
19.30+1.30 (+7.22%)11/13 Close · Vol. 122 lots
—
Line items
Auto Read
Latest
Latest2026 Q3
浩宇生醫(6872)'s 2026 Q3 financial highlights: Operating CF −29.4M · Free cash flow 86.7M · Investing CF 116.1M.
Operating CF
−29.4M
Free cash flow
86.7M
Investing CF
116.1M
About This Metric
Definition
Quarterly figures from the income statement, balance sheet and cash flow statement.
How to Read
Operating cash flow often reveals earnings quality better than reported net income.
Source
MOPS
How much time do you spend wiring APIs, pulling data, and debugging — instead of thinking about strategy? Describe the signal, and Blave Agent researches and backtests it.
See what Blave Agent can do →